Large Zealand shareholder considers investing in Orphazyme
Dutch family foundation Van Herk, which owns a fifth of shares in Zealand Pharma, is considering buying shares in another Danish biotech company: Orphazyme.
The Dutch, family-owned private trust Van Herk may not have finished investing in Danish biotech companies. This comes after the fund recently invested DKK 560 million (USD 82 million) in Zealand Pharma.
Allerede abonnent?Log ind her
Læs hele artiklen
Få adgang i 14 dage for 0 kr. Det kræver intet kreditkort, og du vil ikke overgå til et betalt abonnement efterfølgende.
